Skip to content

Retinol-induced Dermatitis in Aged Skin

Molecular Analyses of Retinoid-induced Dermatitis in Aged/Photoaged Human Skin

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00857610
Enrollment
41
Registered
2009-03-06
Start date
2009-07-20
Completion date
2014-08-29
Last updated
2020-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aged Skin, Photoaged Skin

Keywords

Aged skin, Photoaged skin, Retinol, Topical retinoids

Brief summary

Topical therapy with retinoids is the only proven medical therapy for aged/photoaged human skin. However, topical therapy with retinoids often result in unwanted cutaneous dermatitis, including erythema and scaling. The reseachers intend to investigate the dose, frequency of use, and time dependence of topical retinol-induced dermatitis. The researchers intend to evaluate retinoid-induced dermatitis biochemically, including retinol regulation of retinoid responsive genes that control retinoid metabolism and serve as markers for retinoid bioactivity. The researchers will also investigate the role of EGF receptor pathway in retinoid-induced dermatitis.

Interventions

None listed

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female * Subject is at least 21 years of age * Good general health * No disease states, physical conditions or medications that would impair evaluation of the test sites * Willingness and ability to follow protocol * Signed written and witnessed informed consent form * No use of oral retnoids in the past year * No use of topical steroids to the treatment area in the past 2 weeks

Exclusion criteria

* Has received an experimental drug or used and experimental device in the 14 days prior to admission to the study * History of keloids * History of hypersensitivity to lidocaine or epinephrine * Pregnant or nursing women * Disease states or physical condition that would impair evaluation of the test sites or compliance with the protocol * History of chemical peels or laser treatments to the sites evaluated

Design outcomes

Primary

MeasureTime frame
Retinoid-induced dermatitis6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026